This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
What are the incidence and mortality rates of cancers in Delaware?
Tracking cancer incidence and treatment in Delaware
Challenge
Cancer affects millions of Americans yearly and remains a significant public health issue in the U.S. According to the American Cancer Society, cancer is a leading cause of death in the U.S. with the incidence continuing to grow among the U.S. population. The most commonly diagnosed cancers include breast, lung, prostate, and colorectal cancers.
Impacts from cancer include premature death, lower quality of life, comorbid disorders, economic burden, and stress (financial, emotional, social, and mental) on the patient, family, and friends.
Solution
In addressing the cancer burden, surveillance is essential. Cancer surveillance refers to the ongoing monitoring of cancer in populations and individuals, primarily for early detection, treatment, and management. Surveillance is necessary to assess burden and to implement cancer control and outreach.
Surveillance in a central cancer registry also allows research of cancer trends and treatment on a population level.
Results
Registry data informs policymakers, funding, cancer control efforts, researchers, outreach programs, providers, and the public.
Focus Areas
Clinical Trials Disease Epidemiology Public HealthCapabilities
Biostatistics and Epidemiology Data CollectionSenior Expert Contact
Wilhelmina Ross
Senior Research Associate
-
Perspective
Westat Experts Present at AAPOR 2025May 2025
Westat’s public opinion and survey methodology experts are heading to the 80th Annual American Association for Public Opinion Research (AAPOR) Conference, in St. Louis, MO,…
-
Expert Interview
Why Are People Reluctant to Share Health App Data?May 2025
In an age where smart watches track our heart rate, apps detect our sleep patterns, and digital platforms monitor the calories we burn, the potential…
-
Expert Interview
Fine-Tuning LLMs to Improve Adverse Drug Event Detection and ReportingApril 2025
The expedient, accurate detection of the severity of adverse drug events (ADEs) remains a serious challenge. Despite technological advancements, data-driven models often fail to precisely…